Uses of Amphiphiles in Immune Cell Therapy and Compositions Therefore
Invention type: Technology
/
Case number: #21411H
Provided herein are methods for stimulating an immune response to a target cell population or a target tissue in a subject by administering to the subject a composition comprising an amphiphilic ligand conjugate. Such an amphiphilic ligand conjugate can comprise a lipid, one or more cargos (e.g., a CAR ligand, a chimeric cytokine receptor target, a chimeric co-stimulation receptor target, a synNotch receptor target), and optionally a linker.
Researchers
Peter DeMuth
/
Darrell J Irvine
Departments: David H Koch Institute for Integrative Cancer Res
Technology Areas: Chemicals & Materials: Polymers / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
uses of amphiphiles in immune cell therapy and compositions therefor
United States of America | Published application | 0 -
uses of amphiphiles in immune cell therapy and compositions therefor
European Patent Convention | Published application -
uses of amphiphiles in immune cell therapy and compositions therefor
Japan | Published application -
uses of amphiphiles in immune cell therapy and compositions therefor
Hong Kong | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.